Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 1Eyelid Squamous Cell Carcinoma 1Cholangiocarcinoma 1

Interventions

Gemcitabine 18Cisplatin 13Oxaliplatin 8Capecitabine 7Leucovorin 6Fluorouracil 5pembrolizumab 4Photochemotherapy 3Irinotecan 3ivosidenib 2Cholangiopancreatography, Endoscopic Retrograde 2zanidatamab 1toripalimab 1pemigatinib 1lenvatinib 1infigratinib 1durvalumab 1cemiplimab 1becatecarin 1atezolizumab 1Tissue Adhesives 1Tegafur 1Taxes 1S 1 (combination) 1Radiotherapy, Image-Guided 1Radiation 1Platinum 1Pancreaticojejunostomy 1Nivolumab 1Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Cholangiocarcinoma × Radiotherapy, Image-Guided × Clear all
NCT02200042 2026-05-19

Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer

NRG Oncology

Phase 3 Terminated
1 enrolled 5 charts
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡